The phrase “game-changing” gets bandied about a lot in entrepreneurial circles. And certainly, in this era of landmark technological change, we are spoilt for choice when it comes to people and products that have changed the way we live. We’re about to introduce you to a woman who raises that bar to life-changing. Someone who is paving the way for millions of women to have more personalized, accurate fertility care. One who has truly moved the medical sciences needle. (Pun intended). Piraye Beim, is indeed a rare woman. A mother to two, soon-to-be three, a world-leading genetic scientist and Founder/CEO at Celmatix – the New York biotech firm putting big data through its paces with some remarkable results. Since launching in 2009, Celmatix has released two world-first products. The first is Polaris, a cloud-based platform that uses big data to optimize the treatment of fertility patients. Its creation was what Beim refers to as a “happy accident” on the way to solving their number one goal – building the first genetic test for reproductive health. Fertilome, the realization of that mission, was released early this year. Today, Celmatix are well on their way to empowering an entire generation of women to proactively manage their fertility. And Piraye Beim is just getting started. In this week's episode: How critical it is to your success to be a part of a shared community What the business of medicine is like The importance of understanding the story of your customers How Piraye settles the debate between growth and profitability How to find the time to be both a parent and a game-changing entrepreneur & much more! This podcast episode was brought to you by Pipedrive. Made by marketers for marketers and with over 30,000 users worldwide, Pipedrive is one of the best CRM tools in the business. Keep track of all your sales, customers, and leads with their incredibly intuitive dashboard and simple design. Don't try any other CRM tool until you've used Pipedrive first!

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related